Professor Paul Greenhaff of the School of Biomedical Sciences at the University of Nottingham, U.K. may have unveiled a new spin on L- carnitine that the University is negotiating to commercialize with an ethical-based sports nutrition company.
L-carnitine is a compound responsible for transport of fatty acids into a cell’s mitochondria. Favorable results have been reported for many years with regard to the use of L-carnitine in the treatment of cardiovascular diseas
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.